Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 20/20 | 0.61 |
| ▸ | BCL2L1 | Q07817 | 13/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29657285 | 1.00 | BCL2 (0.61) | BCL2BCL2L1CYP2C9 | |
| SCHEMBL29657389 | 0.92 | BCL2 (0.61) | BCL2BCL2L1 | |
| SCHEMBL2724654 | 0.92 | BCL2 (0.61) | BCL2BCL2L1 | |
| SCHEMBL30313851 | 0.89 | BCL2 (0.63) | BCL2BCL2L1 | |
| SCHEMBL2724019 | 0.89 | BCL2 (0.60) | BCL2BCL2L1CYP2C9 | |
| SCHEMBL29657441 | 0.89 | BCL2 (0.60) | BCL2BCL2L1CYP2C9 | |
| SCHEMBL30314012 | 0.89 | BCL2 (0.63) | BCL2BCL2L1 | |
| SCHEMBL2730313 | 0.89 | BCL2 (0.60) | BCL2 | |
| SCHEMBL29657435 | 0.87 | BCL2 (0.72) | BCL2BCL2L1CYP2C9 | |
| SCHEMBL29657415 | 0.85 | BCL2 (0.62) | BCL2BCL2L1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2435432-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | Abbott Laboratories (US) | 2012-04-04 | — | — | EP | claimed |
| WO-2010138588-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2010-12-02 | — | — | WO | claimed |
| EP-2576546-A1 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | Abbvie Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2435432-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | Abbott Laboratories (US) | 2012-04-04 | — | — | EP | disclosed |
| WO-2010138588-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2010-12-02 | — | — | WO | disclosed |